2024-03-29T10:37:35Z
https://niigata-u.repo.nii.ac.jp/oai
oai:niigata-u.repo.nii.ac.jp:00019887
2022-12-15T03:50:46Z
453:456
471:537:538:1158
4)自家 BMT による造血器腫瘍の治療(シンポジウム 自家骨髄移植の応用, 第482回新潟医学会)
4)自家 BMT による造血器腫瘍の治療(シンポジウム 自家骨髄移植の応用, 第482回新潟医学会)
Autologous Bone Marrow Transplantation for Hematological Malignancies (Application of Autologous BMT to Cancer Treatment)
後藤, 隆夫
岸, 賢治
瀧, 淳
橋本, 誠雄
新国, 公司
樋口, 渉
成田, 美和子
古川, 達雄
鳥羽, 健
品田, 章二
森山, 美昭
autologus bone marrow transplantation
Hematological malignancy
Graft-versus-leukemia effect
自家骨髄移植
造血器腫瘍
Intensive chemoradiotherapy with autologous bone marrow transplantation (ABMT) has been explored as a treatment for hematological malignancies. Ten cases with acute leukemia and Hodgkin's disease were treated with high dose chemotherapy followed by autologous marrow cells (2 unpurged, 8 purged). Six leukemia relapse were observed between day 28 to 331 days after ABMT in 9 patients with hematological reconstitution. One case was dead of interstitial pnemonitis and two are alive without relapse. Attempts to remove minimal residual disease from the harvested marrow have been made by several ex vivo purging methods, but the effects of such procedures have not yet been clarified. In this airticle, we showed the present condition and problems of ABMT in hematological malignancies.
新潟医学会
1993-09
jpn
departmental bulletin paper
http://hdl.handle.net/10191/37679
https://niigata-u.repo.nii.ac.jp/records/19887
AN00182415
00290440
新潟医学会雑誌
新潟医学会雑誌
107
9
802
807
https://niigata-u.repo.nii.ac.jp/record/19887/files/107(9)_802-807.pdf
application/pdf
2.9 MB
2019-08-16